Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2024

Feb 28, 2024

30561_dirs_2024-02-27_6382651e-9557-42a6-9f67-58323c9377c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2024-02-23

Reporting Person: Haley Patrick J. (EVP, Commercial)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-02-23 Common Stock A 63350 Acquired 431886 Direct
2024-02-23 Common Stock S 47020 $21.45 Disposed 384866 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23539 Indirect
Common Stock 10648 Indirect

Footnotes

F1: Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock.

F2: The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original
number of shares subject to the restricted stock unit award on May 15, 2025 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested.

F3: Includes 300,823 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F4: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.44 to $21.48. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.

F5: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 22, 2024.